FOXA Insider Activity: Ciongoli RSU Vesting and Share Sales Reported
Rhea-AI Filing Summary
Adam G. Ciongoli, Chief Legal and Policy Officer of Fox Corporation (FOXA), reported transactions dated 08/15/2025. The filing shows two restricted stock unit vesting events totaling 25,496 and 14,836 RSUs, and two share dispositions of 12,803 and 7,450 shares sold at $59.89 per share. Each RSU represents one share of Class A common stock. The reported beneficial ownership figures following the transactions appear in the filing and range in the table entries from 58,489 to 73,325 shares depending on the line item. The form is signed by an attorney-in-fact and contains vesting schedules for the awards.
Positive
- RSU vesting disclosed showing compensation being realized through planned tranches (25,496 and 14,836 RSUs).
- Transparent reporting with explicit share counts, sale prices ($59.89) and vesting schedule details included in the filing.
Negative
- Share disposals occurred (12,803 and 7,450 shares sold) reducing the insider's immediate shareholdings.
- No indication of a 10b5-1 plan on the form, so sales are not identified as pre-arranged trades claiming affirmative defense.
Insights
TL;DR: Insider reported RSU vesting and partial sales on the same date; routine compensation vesting with modest sell-down.
The filing documents customary restricted stock unit vesting for an executive and contemporaneous disposals of vested shares at $59.89 per share. The transactions reflect compensation realization rather than an open-market accumulation or a large-scale divestiture. The amounts sold (12,803 and 7,450 shares) are meaningful at the individual level but are not presented as unusually large relative to the company as a whole in this filing. No derivatives other than RSUs are exercised beyond conversion to Class A shares as indicated.
TL;DR: Filing shows standard executive vesting schedule and sales; disclosures comply with Section 16 reporting.
The submission includes explicit explanations of the RSU vesting tranches and timing, indicating scheduled vesting over multiple years. Sales were reported and a third-party attorney-in-fact signed the form, consistent with procedural norms. There is no indication of a Rule 10b5-1 plan check box being marked, so the filing does not assert an affirmative defense under such a plan.